277 related articles for article (PubMed ID: 18480864)
1. [Survival in adults with acute myelogenous leukemia].
Tangen JM; Fløisand Y; Foss-Abrahamsen J; Haukås E; Naess IA; Skjelbakken T
Tidsskr Nor Laegeforen; 2008 May; 128(10):1164-7. PubMed ID: 18480864
[TBL] [Abstract][Full Text] [Related]
2. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
Fukushima T; Ueda T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
[TBL] [Abstract][Full Text] [Related]
3. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
[TBL] [Abstract][Full Text] [Related]
4. [Survival in adults with acute lymphoblastic leukaemia].
Tangen JM; Fløisand Y; Haukås E; Naess IA; Skjelbakken T; Stapnes C; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1710-3. PubMed ID: 20835280
[TBL] [Abstract][Full Text] [Related]
5. [Recent progress in the treatment of acute leukemia].
Kimura Y
Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
[TBL] [Abstract][Full Text] [Related]
6. [Complications associated with short-term intensive consolidation chemotherapy for adults with acute myelogenous leukemia].
Nagata K; Abe Y; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1869-72. PubMed ID: 8379681
[No Abstract] [Full Text] [Related]
7. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
9. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
[TBL] [Abstract][Full Text] [Related]
10. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
11. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
[TBL] [Abstract][Full Text] [Related]
12. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
13. Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia.
Szotkowski T; Jarosova M; Faber E; Hubacek J; Hlusi A; Papajik T; Pikalova Z; Kucerova L; Holzerova M; Budikova M; Buriankova E; Plachy R; Potomkova J; Klusova N; Szotkowska R; Indrak K
Onkologie; 2009 Sep; 32(8-9):513-5. PubMed ID: 19745598
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in acute leukemia. Twenty-two adult patients surviving for over five years.
Evensen SA; Stavem P
Acta Med Scand; 1986; 219(1):79-83. PubMed ID: 3456695
[TBL] [Abstract][Full Text] [Related]
15. [Childhood acute lymphoblastic leukemia in Norway 1992-2000].
Kolmannskog S; Flaegstad T; Helgestad J; Hellebostad M; Zeller B; Glomstein A
Tidsskr Nor Laegeforen; 2007 May; 127(11):1493-5. PubMed ID: 17551551
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
Balleisen S; Kuendgen A; Hildebrandt B; Haas R; Germing U
Leuk Res; 2009 Sep; 33(9):1189-93. PubMed ID: 19428106
[TBL] [Abstract][Full Text] [Related]
17. Leukemia: A model for drug development.
Keating MJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2598-604. PubMed ID: 9815664
[TBL] [Abstract][Full Text] [Related]
18. Relapse and death during first remission in acute myeloid leukemia.
Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E
Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012
[No Abstract] [Full Text] [Related]
19. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
Montillo M; Ricci F; Tedeschi A; Cafro AM; Nosari AM; Nichelatti M; Marbello L; Morra E
Leuk Res; 2009 Aug; 33(8):1072-8. PubMed ID: 19187960
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
Rizzieri DA; O'Brien JA; Broadwater G; Decastro CM; Dev P; Diehl L; Beaven A; Lagoo A; Gockerman JP; Chao NJ; Moore JO
Cancer; 2009 Jul; 115(13):2922-9. PubMed ID: 19452542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]